In addition, three hub genes (SPARC, COL6A3, and FBN1) may also play a vital role in the microenvironment of pancreatic cancer through the regulation of tumor-infiltrating immune cells, suggesting they could serve as potential therapeutic targets for the modulation of the antitumor immune response. Here, COL6A3 is linked to familial pancreatic carcinoma.